The Medical Director partners closely with stakeholders across research and development, operations, biostatistics, medical affairs, market access, regulatory affairs, commercial, and executive leadership to develop and execute a cohesive clinical strategy across multiple tumor types and indications. This individual serves as the medical lead for the development, validation, and clinical adoption of MRD and circulating tumor DNA (ctDNA)-based technologies, advancing precision oncology through innovative molecular diagnostics that improve patient outcomes across the cancer care continuum.